›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:Liquid Trace™ Solid Tumor
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Genomic Testing CooperativeType:
Laboratory Developed Test
Related tests:
GTC’s Liquid Trace is a pan-cancer test evaluating cfRNA and cfDNA providing highly informative data that can be used for diagnoses, evaluating the host immune response, and identifying biomarkers for predicting responses to various therapies.
Cancer:
Solid Tumor
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), EWSR1 (EWS RNA Binding Protein 1), HER-2 (Human epidermal growth factor receptor 2)
See More ...
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), EWSR1 (EWS RNA Binding Protein 1), HER-2 (Human epidermal growth factor receptor 2), HRAS (Harvey rat sarcoma viral oncogene homolog), HRD (Homologous Recombination Deficiency), KRAS (KRAS proto-oncogene GTPase), MET (MET proto-oncogene, receptor tyrosine kinase), NRAS (Neuroblastoma RAS viral oncogene homolog), NTRK (Neurotrophic receptor tyrosine kinase), NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2), NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3), PD-L1 (Programmed death ligand 1), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PTEN (Phosphatase and tensin homolog), RET (Ret Proto-Oncogene), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS), TMB (Tumor Mutational Burden)
Method:
Liquid biopsy / cfRNA / cfDNA
